Home › Stocks › KAPA

Kairos Pharma, LTD. (KAPA): insider buying, hedge funds & Congress trades

Kairos Pharma, LTD. (KAPA): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Nov 25, 2024Samuelson Doug
Officer
2,500$1.50$3.8Kno history
Nov 25, 2024Murali Ramachandran
Officer
200$1.59$318no history
Nov 21, 2024Yu John S
Director, Officer, TenPercentOwner
4,000$1.44$5.8Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for KAPA

Free account. Know when insiders, famous funds or Congress trade it.

Start free